What is NDC 0074-0282?

0074-0282 is the product NDC for Decnupaz (pivekimab sunirine-pvzy), Pivekimab sunirine 2 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by AbbVie Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Decnupaz (Pivekimab sunirine-pvzy).

AbbVie Inc., NDC labeler code 0074. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Decnupaz?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Decnupaz NDC 0074-0282 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0074-0282Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00074-0282Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0074-0282-02	00074028202	1 VIAL, SINGLE-DOSE in 1 CARTON (0074-0282-02) / 1.15 mL in 1 VIAL, SINGLE-DOSEMarketed from May 27, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Decnupaz
Generic name (nonproprietary): pivekimab sunirine-pvzy
Active ingredients: Pivekimab sunirine — 2 mg/mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: AbbVie Inc.NDC labeler code 0074
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 761460
Marketing start: May 27, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 0074-0282_a7f31acd-4120-420a-ab5d-10415866e41aSPL ID a7f31acd-4120-420a-ab5d-10415866e41aSPL set ID 508b6ff8-601d-4901-a7a5-816141134054RxCUI 2744303, 2744309UNII L15LO3W1XX

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400074028202 followed by a unit qualifier and the quantity

Package 00074-0282-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 27, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE DECNUPAZ is indicated for the treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). DECNUPAZ is a CD123-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0074-0282

What is NDC 0074-0282?: 0074-0282 is the product NDC for Decnupaz (pivekimab sunirine-pvzy), Pivekimab sunirine 2 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by AbbVie Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Decnupaz (Pivekimab sunirine-pvzy).
What is the active ingredient?: Pivekimab sunirine.
Who is the labeler?: AbbVie Inc., NDC labeler code 0074. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Decnupaz?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Decnupaz (Pivekimab sunirine-pvzy) NDC 0074-0282